Cargando…

Toll-like receptors and COVID-19: a two-faced story with an exciting ending

Detalles Bibliográficos
Autores principales:	Onofrio, Livia, Caraglia, Michele, Facchini, Gaetano, Margherita, Vincenzo, Placido, Sabino De, Buonerba, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434222/ https://www.ncbi.nlm.nih.gov/pubmed/32974046 http://dx.doi.org/10.2144/fsoa-2020-0091

Ejemplares similares

TIRAP, TRAM, and Toll-Like Receptors: The Untold Story
por: Lannoy, Valérie, et al.
Publicado: (2023)

Urologic malignancies: advances in the analysis and interpretation of clinical findings
por: Crocetto, Felice, et al.
Publicado: (2021)

The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?
por: Montella, Liliana, et al.
Publicado: (2022)

Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma
por: Rosa, Roberta, et al.
Publicado: (2013)

Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2013)

Evolution of the chicken Toll-like receptor gene family: A story of gene gain and gene loss
por: Temperley, Nicholas D, et al.
Publicado: (2008)

Cannabinoids in Glaucoma Patients: The Never-Ending Story
por: Passani, Andrea, et al.
Publicado: (2020)

Complete Response and Fatigue Improvement With the Combined Use of Cyclophosphamide and Quercetin in a Patient With Metastatic Bladder Cancer: A Case Report
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2016)

Docetaxel Rechallenge in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer: A Case Report and Review of Literature
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2016)

The evolving landscape in advanced penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2015)

High-dose fotemustine in temozolomide-pretreated glioblastoma multiforme patients: A phase I/II trial
por: Marinelli, Alfredo, et al.
Publicado: (2018)

An epigenomic mechanism in retinoblastoma: the end of the story?
por: Murphree, A Linn, et al.
Publicado: (2012)

Sarin: a never-ending story
por: Bolt, Hermann M.
Publicado: (2022)

The TANSNIP-PESA trial is not the end of the story
por: Näslund, Ulf, et al.
Publicado: (2023)

A never-ending story: the steadily growing family of the FA and FA-like genes
por: Gueiderikh, Anna, et al.
Publicado: (2017)

Toward a Personalized Therapy in Soft-Tissue Sarcomas: State of the Art and Future Directions
por: Montella, Liliana, et al.
Publicado: (2021)

Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story
por: Bisceglia, Irma, et al.
Publicado: (2022)

Testicular cancer from diagnosis to epigenetic factors
por: Boccellino, Mariarosaria, et al.
Publicado: (2017)

Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review)
por: Del Pup, Lino, et al.
Publicado: (2016)

A model of face selection in viewing video stories
por: Suda, Yuki, et al.
Publicado: (2015)

PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study
por: Bosso, Davide, et al.
Publicado: (2017)

The lipid story in chronic kidney disease: a long story with a happy end?
por: Kujawa-Szewieczek, Agata, et al.
Publicado: (2012)

Corrigendum: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story
por: Bisceglia, Irma, et al.
Publicado: (2022)

Corrigendum: Cardio-oncology in the COVID Era (Co & Co): The never-ending story
por: Bisceglia, Irma, et al.
Publicado: (2023)

Toll‐like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis
por: Mokhtari, Yazdan, et al.
Publicado: (2020)

Facioscapulohumeral muscular dystrophy: Are telomeres the end of the story?
por: Stadler, Guido, et al.
Publicado: (2013)

Saturated fat –a never ending story?
por: Svendsen, Karianne, et al.
Publicado: (2017)

Doping in Sports, a Never-Ending Story?
por: Vlad, Robert Alexandru, et al.
Publicado: (2018)

Mystic Acetaldehyde: The Never-Ending Story on Alcoholism
por: Peana, Alessandra T., et al.
Publicado: (2017)

Atrial fibrillation: A never ending story?
por: Lanters, Eva A. H., et al.
Publicado: (2019)

Golden cats: A never‐ending story!
por: Abitbol, Marie, et al.
Publicado: (2022)

Parkinson’s disease: a never ending story
por: Reichmann, Heinz, et al.
Publicado: (2023)

Kawasaki Disease: A Never-ending Story?
por: Lianza, Alessandro Cavalcanti, et al.
Publicado: (2023)

A never-ending FLT3 story
por: Kiyoi, Hitoshi
Publicado: (2023)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Evidence for Activation of Toll-Like Receptor and Receptor for Advanced Glycation End Products in Preterm Birth
por: Noguchi, Taketoshi, et al.
Publicado: (2010)

Immunotherapy for penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2017)

The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
por: Petes, Carlene, et al.
Publicado: (2017)

Natural Products with Toll-Like Receptor 4 Antagonist Activity
por: Molteni, Monica, et al.
Publicado: (2018)

The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation
por: Molteni, Monica, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k1c3p3hu390t4m91fk7j1s18b0